Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea

Lupus

Volumn 23, Issue 14, 2014, Pages 1449-1451

  Brogna, C ^a   Mariotti, P ^a   Manna, R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY; PRIMOZIDE; RISPERIDONE; UNCLASSIFIED DRUG; IMMUNOGLOBULIN;

ANTIPHOSPHOLIPID ANTIBODIES RELATED CHOREA; ANTIPHOSPHOLIPID SYNDROME; BRAIN; CHILDHOOD DISEASE; CHOREA MINOR; DISEASE ASSOCIATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; EPILEPSY; HUMAN; IMMUNOTHERAPY; MIGRAINE; MOTOR DYSFUNCTION; NERVE CELL; PLASMAPHERESIS; STREPTOCOCCUS INFECTION; SURFACE PROPERTY; CHILD; CHOREA; COMPLICATION;

ANTIPHOSPHOLIPID SYNDROME; CHILD; CHOREA; DOPAMINE ANTAGONISTS; HALOPERIDOL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; RISPERIDONE;

EID: 84911090835     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314551084     Document Type: Editorial

References (29)

1. Hughes GR. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. BMJ. 1983 ; 287: 1088-1089
2. Avcin T, Cimaz R, Silverman ED, et al. Pediatric antiphospholipid syndrome: Clinical and immunologic features of 121 patients in an international registry. Pediatrics. 2008 ; 122: 1100-1107
3. Dale RC, Yin K, Ding A, et al. Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies. Dev Med Child Neurol. 2011 ; 53: 522-528
4. Weiner SG, Normandin PA. Sydenham chorea: A case report and review of literature. Pediatric Emerg Care. 2007 ; 23: 20-24
5. Torreggiani S, Torcoletti M, Cuoco F, Di Landro G, Petaccia A, Corona F. Chorea, a little-known manifestation in systemic lupus erythematosus: Short literature review and four case reports. Pediatric Rheumatology Online J. 2013 ; 11: 36-36
6. Benseler SM, Silverman ED. Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus. 2007 ; 16: 564-571
7. Avcin T, Silverman ED. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus. 2007 ; 16: 627-633
8. Avcin T. Antiphospholipid syndrome in children. Curr Opin Rheumatol. 2008 ; 20: 595-600
9. Cervera R, Asherson RA, Font J, et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore). 1997 ; 76: 203-122
10. Soltesz P, Der H, Veres K, et al. Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology (Oxford). 2008 ; 47: 1628-1634
11. Katzav A, Chapman J, Shoenfeld Y. CNS dysfunction in the antiphospholipid syndrome. Lupus. 2003 ; 12: 903-907
12. Wallker KG, Wilmshurst JM. An update on the treatment of Sydenham's chorea: The evidence for established and evolving interventions. Ther Adv Neurol Disord. 2010 ; 3: 301-309
13. Cardoso F. Sydenham's chorea. Current Treat Options Neurol. 2008 ; 10: 230-235
14. Peluso S, Antenora A, De Rosa, et al. Antiphospholipid-related chorea. Front Neurol. 2012 ; 3: 150-150
15. Genel F, Arslanoglu S, Uran N, Saylan B. Sydenham's chorea: Clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev. 2002 ; 24: 73-76
16. Cardoso F, Maia D, Cunningham MC, Valença C. Treatment of Sydenham chorea with corticosteroids. Mov Disord. 2003 ; 18: 1374-1377
17. Paz JA, Silva CA, Marques-Dias MJ. Randomized double-blind study with prednisolone in Sydenham's chorea. Pediatr Neurol. 2006 ; 4: 264-269
18. Teixera AL, Maia DP, Cardoso F. Treatment of acute Sydenham's chorea with methylprednisolone pulse-therapy. Parkinsonism Relat Disord. 2005 ; 11: 327-330
19. Fusco C, Ucchino V, Frattini D, Pisani F, Della Giustina E. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea. Eur J Paediatr Neurol. 2012 ; 16: 373-378
20. van Immerzeel TD, van Gilst RM, Hartwig NG. Beneficial use of immunoglobulins in the treatment of Sydenham chorea. Eur J Pediatr. 2010 ; 169: 1151-1154
21. Lazurova I, Macejova Z, Benhatchi K, et al. Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea. Clin Rheumatol. 2007 ; 26: 2145-2147
22. Orzechowski NM, Wolanskyj AP, Ahlskog JE, Kumar N, Moder KG. Antiphospholipid antibody-associated chorea. J Rheumatol. 2008 ; 35: 2165-2170
23. Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A. Effective treatment of antiphospholipid syndrome with plasmapheresis and rituximab. Hippokratia. 2010 ; 14: 215-216
24. Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol. 2005 ; 20: 424-429
25. Walker K, Brink A, Lawewnson J, Mathiassen W, Wilmshurst JM. Treatment of Sydenham chorea with intravenous immunoglobulin. J Child Neurol. 2012 ; 27: 147-155
26. Appenzeller S, Yeh S, Marujama M, Barros SM, de Carvalho JF. Chorea in primary antiphospholipid syndrome is associated with rheumatic fever. Rheumatol Int. 2012 ; 32: 2857-2861
27. Blank M, Krause I, Magrini L, et al. Overlapping humoral and autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford). 2006 ; 45: 833-841
28. Brogna C, Manna R, Olivieri, et al. Intravenous immunoglobulin therapy in pediatric antiphospholipid-related chorea. The Ninth International Congress on Autoimmunity, Session: PS18 - IVIG and Autoimmunity, Nice, France, 26-30 March 2014.
29. Routsias JG, Kyriakidis NC, Friedman DM, et al. Association of the idiotype: Antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. Arthritis Rheum. 2011 ; 63: 2783-2789